Project Farma Welcomes Industry Veteran Richard Tree as Chief Operating Officer 

Shelton, CT, April 23, 2025 – Project Farma (PF), a leading life sciences consultancy focused on advancing technical operations from ideation through commercialization, today announced the appointment of Richard Tree as Chief Operating Officer, effective April 21, 2025. 

As COO, Rich will focus on scaling Project Farma’s infrastructure and guiding strategic initiatives that expand our reach and amplify our impact, while strengthening our position as the preferred solution provider for global pharma organizations and deepening our commitment to the patients.  

“Rich’s exceptional leadership capabilities and strategic vision make him the ideal executive to help steer Project Farma through our next phase of growth,” said Anshul Mangal, CEO of Project Farma. “His proven ability to transform operations and scale organizations aligns perfectly with our mission to accelerate the delivery of life-changing therapies to patients worldwide.” 

Rich has been leading life science service organizations for over a decade. He is a veteran of the US Navy, and holds a Doctorate Degree in Engineering Management, an MBA, and executive certifications from Standford University and Harvard Business School. Rich also brings deep expertise in Lean Six Sigma, organizational design, and business strategy, along with decades of leadership across the life sciences, manufacturing, and consulting industries.  

Rich joins Project Farma from CAI where he oversaw global operations. Throughout his career, he has consistently delivered operational excellence, performance improvements, and sustainable growth in competitive markets. 

“I’m thrilled to join the highly skilled team at Project Farma at such a pivotal moment in its journey,” said Rich. “Project Farma’s track record and patient-focused culture is inspiring and I look forward to bringing my operational experience to strengthen the mission of accelerating patients’ access to transformative treatments.”  

About Project Farma 

Project Farma is a patient-focused global leader in advancing technical operations from ideation through commercialization with a proven track record of planning, building, and maintaining manufacturing facilities, capital expansions, and technical operations for complex biologics and novel modalities. Project Farma has executed 100+ facility builds, retrofits and expansions, managed 400+ large-scale capital projects, industrialized 10+ commercial cell, gene, and novel therapies, and managed $6B+ in technical operations capital investments. 

Partnering with leading pharmaceutical companies, advanced therapy organizations, universities, hospitals, and government agencies, our team of experts drives innovation in technical operations and manufacturing to support the advancement of groundbreaking therapies for patients in need. For more information, visit www.projectfarma.com